{"entity":{"type":"insider","cik":"0001808895","url":"/insider/0001808895","json_url":"/insider/0001808895.json","name":"Coulie Bernard","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":51,"n_filings":22,"first":"2020-12-16","last":"2026-01-22","span_basis":"filed_date"},"name_variants":[{"name":"Coulie Bernard","source":"filing","n_filings":22,"first_seen":"2020-12-16","last_seen":"2026-01-22"}],"transactions":[{"id":5911031,"accession":"0001746473-26-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001746473-26-000009","line_url":"/filing/0001746473-26-000009#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89375.0,"shares_display":"89,375","price_per_share":1.28,"price_display":"1.28","price_state":"stated","total_value":114400.0,"total_display":"114,400.00","total_whole":"114,400","shares_owned_after":505601.0,"shares_owned_after_display":"505,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-22","scope":"insider"},{"id":4896674,"accession":"0001746473-25-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001746473-25-000006","line_url":"/filing/0001746473-25-000006#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52419.0,"shares_display":"52,419","price_per_share":11.2011,"price_display":"11.20","price_state":"stated","total_value":587150.4609,"total_display":"587,150.46","total_whole":"587,150","shares_owned_after":430517.0,"shares_owned_after_display":"430,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-17","filed_date":"2025-01-22","scope":"insider"},{"id":2707768,"accession":"0001746473-24-000123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001746473-24-000123","line_url":"/filing/0001746473-24-000123#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38710.0,"shares_display":"38,710","price_per_share":11.56,"price_display":"11.56","price_state":"stated","total_value":447487.6,"total_display":"447,487.60","total_whole":"447,488","shares_owned_after":482936.0,"shares_owned_after_display":"482,936","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-10","filed_date":"2024-07-12","scope":"insider"},{"id":2707765,"accession":"0001746473-24-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001746473-24-000003","line_url":"/filing/0001746473-24-000003#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25721.0,"shares_display":"25,721","price_per_share":17.23,"price_display":"17.23","price_state":"stated","total_value":443172.83,"total_display":"443,172.83","total_whole":"443,173","shares_owned_after":316382.0,"shares_owned_after_display":"316,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-19","scope":"insider"},{"id":8372773,"accession":"0001209191-23-042823","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-042823","line_url":"/filing/0001209191-23-042823#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70150.0,"shares_display":"70,150","price_per_share":18.0091,"price_display":"18.01","price_state":"stated","total_value":1263338.365,"total_display":"1,263,338.36","total_whole":"1,263,338","shares_owned_after":342103.0,"shares_owned_after_display":"342,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-17","filed_date":"2023-07-19","scope":"insider"},{"id":8575221,"accession":"0001209191-23-022362","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-022362","line_url":"/filing/0001209191-23-022362#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35339.0,"shares_display":"35,339","price_per_share":26.5209,"price_display":"26.52","price_state":"stated","total_value":937222.0851,"total_display":"937,222.09","total_whole":"937,222","shares_owned_after":274753.0,"shares_owned_after_display":"274,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-30","filed_date":"2023-04-03","scope":"insider"},{"id":7808092,"accession":"0001140361-23-004735","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-23-004735","line_url":"/filing/0001140361-23-004735","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":33.61333612,"price_display":"33.61","price_state":"stated","total_value":504200.0418,"total_display":"504,200.04","total_whole":"504,200","shares_owned_after":245374.0,"shares_owned_after_display":"245,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-03","filed_date":"2023-02-06","scope":"insider","n_lines":2},{"id":7808078,"accession":"0001140361-23-004735","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-23-004735","line_url":"/filing/0001140361-23-004735","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":34.2153207,"price_display":"34.22","price_state":"stated","total_value":513229.8105,"total_display":"513,229.81","total_whole":"513,230","shares_owned_after":241717.0,"shares_owned_after_display":"241,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-02","filed_date":"2023-02-06","scope":"insider","n_lines":2},{"id":8604442,"accession":"0001140361-23-003977","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001140361-23-003977","line_url":"/filing/0001140361-23-003977","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":34.3844366,"price_display":"34.38","price_state":"stated","total_value":515766.549,"total_display":"515,766.55","total_whole":"515,767","shares_owned_after":245657.0,"shares_owned_after_display":"245,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-01","scope":"insider","n_lines":3},{"id":8604432,"accession":"0001140361-23-003977","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-23-003977","line_url":"/filing/0001140361-23-003977#line-6","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":34.917,"price_display":"34.92","price_state":"stated","total_value":523755.0,"total_display":"523,755.00","total_whole":"523,755","shares_owned_after":240112.0,"shares_owned_after_display":"240,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-01","scope":"insider"},{"id":8604423,"accession":"0001140361-23-003977","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-23-003977","line_url":"/filing/0001140361-23-003977","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":34.1410344,"price_display":"34.14","price_state":"stated","total_value":512115.516,"total_display":"512,115.52","total_whole":"512,116","shares_owned_after":243717.0,"shares_owned_after_display":"243,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-02-01","scope":"insider","n_lines":2},{"id":7828170,"accession":"0001140361-23-003177","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001140361-23-003177","line_url":"/filing/0001140361-23-003177","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":35.461768364,"price_display":"35.46","price_state":"stated","total_value":886544.2091,"total_display":"886,544.21","total_whole":"886,544","shares_owned_after":409538.0,"shares_owned_after_display":"409,538","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-27","filed_date":"2023-01-27","scope":"insider","n_lines":4},{"id":7828156,"accession":"0001140361-23-003177","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-23-003177","line_url":"/filing/0001140361-23-003177","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":35.19305,"price_display":"35.19","price_state":"stated","total_value":1055791.5,"total_display":"1,055,791.50","total_whole":"1,055,792","shares_owned_after":240112.0,"shares_owned_after_display":"240,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-26","filed_date":"2023-01-27","scope":"insider","n_lines":2},{"id":8571459,"accession":"0001140361-23-002786","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001140361-23-002786","line_url":"/filing/0001140361-23-002786","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":32.501127573333335,"price_display":"32.50","price_state":"stated","total_value":487516.9136,"total_display":"487,516.91","total_whole":"487,517","shares_owned_after":95508.0,"shares_owned_after_display":"95,508","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-25","filed_date":"2023-01-25","scope":"insider","n_lines":2},{"id":8571444,"accession":"0001140361-23-002786","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-23-002786","line_url":"/filing/0001140361-23-002786#line-6","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":30.8926,"price_display":"30.89","price_state":"stated","total_value":463389.0,"total_display":"463,389.00","total_whole":"463,389","shares_owned_after":93812.0,"shares_owned_after_display":"93,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-24","filed_date":"2023-01-25","scope":"insider"},{"id":8571436,"accession":"0001140361-23-002786","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-23-002786","line_url":"/filing/0001140361-23-002786","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":34.55224233333333,"price_display":"34.55","price_state":"stated","total_value":1036567.27,"total_display":"1,036,567.27","total_whole":"1,036,567","shares_owned_after":434317.0,"shares_owned_after_display":"434,317","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-25","scope":"insider","n_lines":3},{"id":8676043,"accession":"0001140361-23-001119","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-23-001119","line_url":"/filing/0001140361-23-001119#line-4","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":19.1658,"price_display":"19.17","price_state":"stated","total_value":95829.0,"total_display":"95,829.00","total_whole":"95,829","shares_owned_after":93812.0,"shares_owned_after_display":"93,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-09","scope":"insider"},{"id":8676039,"accession":"0001140361-23-001119","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-23-001119","line_url":"/filing/0001140361-23-001119#line-2","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":19.0389,"price_display":"19.04","price_state":"stated","total_value":285583.5,"total_display":"285,583.50","total_whole":"285,584","shares_owned_after":93812.0,"shares_owned_after_display":"93,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-06","filed_date":"2023-01-09","scope":"insider"},{"id":8676024,"accession":"0001140361-23-000721","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-23-000721","line_url":"/filing/0001140361-23-000721#line-4","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":19.0627,"price_display":"19.06","price_state":"stated","total_value":285940.5,"total_display":"285,940.50","total_whole":"285,941","shares_owned_after":93812.0,"shares_owned_after_display":"93,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-05","scope":"insider"},{"id":8676012,"accession":"0001140361-23-000721","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-23-000721","line_url":"/filing/0001140361-23-000721#line-2","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":19.3301,"price_display":"19.33","price_state":"stated","total_value":289951.5,"total_display":"289,951.50","total_whole":"289,952","shares_owned_after":93812.0,"shares_owned_after_display":"93,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":6271078,"accession":"0001140361-22-046570","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-046570","line_url":"/filing/0001140361-22-046570#line-2","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34212.0,"shares_display":"34,212","price_per_share":19.1024,"price_display":"19.10","price_state":"stated","total_value":653531.3088,"total_display":"653,531.31","total_whole":"653,531","shares_owned_after":93812.0,"shares_owned_after_display":"93,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-21","scope":"insider"},{"id":6102153,"accession":"0001567619-22-017430","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-017430","line_url":"/filing/0001567619-22-017430#line-2","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12502.0,"shares_display":"12,502","price_per_share":22.5445,"price_display":"22.54","price_state":"stated","total_value":281851.339,"total_display":"281,851.34","total_whole":"281,851","shares_owned_after":59273.0,"shares_owned_after_display":"59,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-12","filed_date":"2022-09-14","scope":"insider"},{"id":6160757,"accession":"0001567619-22-013993","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-22-013993","line_url":"/filing/0001567619-22-013993#line-4","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12498.0,"shares_display":"12,498","price_per_share":22.5,"price_display":"22.50","price_state":"stated","total_value":281205.0,"total_display":"281,205.00","total_whole":"281,205","shares_owned_after":59273.0,"shares_owned_after_display":"59,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-12","filed_date":"2022-07-13","scope":"insider"},{"id":6160751,"accession":"0001567619-22-013993","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-013993","line_url":"/filing/0001567619-22-013993#line-2","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":22.5,"price_display":"22.50","price_state":"stated","total_value":337500.0,"total_display":"337,500.00","total_whole":"337,500","shares_owned_after":59273.0,"shares_owned_after_display":"59,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-11","filed_date":"2022-07-13","scope":"insider"},{"id":5380949,"accession":"0001209191-21-040760","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-040760","line_url":"/filing/0001209191-21-040760","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":33.025595575,"price_display":"33.03","price_state":"stated","total_value":132102.3823,"total_display":"132,102.38","total_whole":"132,102","shares_owned_after":449560.0,"shares_owned_after_display":"449,560","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-14","filed_date":"2021-06-15","scope":"insider","n_lines":2},{"id":5291879,"accession":"0001209191-21-033310","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-033310","line_url":"/filing/0001209191-21-033310","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":28.63555517142857,"price_display":"28.64","price_state":"stated","total_value":100224.4431,"total_display":"100,224.44","total_whole":"100,224","shares_owned_after":453820.0,"shares_owned_after_display":"453,820","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-14","filed_date":"2021-05-17","scope":"insider","n_lines":2},{"id":5246201,"accession":"0001209191-21-026883","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-026883","line_url":"/filing/0001209191-21-026883#line-2","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":30.3318,"price_display":"30.33","price_state":"stated","total_value":106161.3,"total_display":"106,161.30","total_whole":"106,161","shares_owned_after":456817.0,"shares_owned_after_display":"456,817","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-14","filed_date":"2021-04-15","scope":"insider"},{"id":5245596,"accession":"0001209191-21-021563","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-021563","line_url":"/filing/0001209191-21-021563","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":38.5242776,"price_display":"38.52","price_state":"stated","total_value":134834.9716,"total_display":"134,834.97","total_whole":"134,835","shares_owned_after":460495.0,"shares_owned_after_display":"460,495","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider","n_lines":3},{"id":4254444,"accession":"0000899243-21-006984","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-006984","line_url":"/filing/0000899243-21-006984","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":32.671957142857146,"price_display":"32.67","price_state":"stated","total_value":114351.85,"total_display":"114,351.85","total_whole":"114,352","shares_owned_after":464017.0,"shares_owned_after_display":"464,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-17","scope":"insider","n_lines":3},{"id":4811190,"accession":"0000899243-21-002224","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-002224","line_url":"/filing/0000899243-21-002224","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":26.378638,"price_display":"26.38","price_state":"stated","total_value":92325.233,"total_display":"92,325.23","total_whole":"92,325","shares_owned_after":467947.0,"shares_owned_after_display":"467,947","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-14","filed_date":"2021-01-15","scope":"insider","n_lines":2},{"id":2553684,"accession":"0000899243-20-034194","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-034194","line_url":"/filing/0000899243-20-034194#line-2","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001808895","owner_name":"Coulie Bernard","owner_display_name":"Coulie Bernard","owner_url":"/insider/0001808895","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3163.0,"shares_display":"3,163","price_per_share":27.3164,"price_display":"27.32","price_state":"stated","total_value":86401.7732,"total_display":"86,401.77","total_whole":"86,402","shares_owned_after":471154.0,"shares_owned_after_display":"471,154","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-16","scope":"insider"}],"collapsed":true,"next_cursor":"2020-12-14|2553684","ledger_fault":false,"count":{"value":51,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":51,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":51},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001746473","name":"PLIANT THERAPEUTICS, INC.","url":"/issuer/0001746473","role":"Director, Officer (President and CEO)","n_filings":22,"first_seen":"2020-12-16","last_seen":"2026-01-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001808895","retrieved_at":"2026-08-27T03:42:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}